文献速递中医内科中药与中成药合理使用

铁死亡调控:中医药治疗慢性萎缩性胃炎的新机制

Modulation of Ferroptosis: A Novel Mechanism of Traditional Chinese Medicine in Managing Chronic Atrophic Gastritis.
PubMed 文献 · Am J Chin Med · 2026-06-18

慢性萎缩性胃炎是胃癌前病变,西医逆转胃黏膜损伤疗效有限。本文综述铁死亡在CAG发病中的九条核心通路,总结黄芩素、姜黄素、丹参酮IIA、黄芪甲苷及四君子汤、半夏泻心汤、摩罗丹、胃复春等调控铁死亡相关信号通路的研究进展,凸显中医药多靶点、多途径减轻氧化损伤、促进黏膜修复的特征。

要点

  • 铁死亡是CAG胃黏膜损伤与进展的关键驱动因素,涉及铁代谢失衡、GSH耗竭、LPO等九条通路。
  • 黄芩素、姜黄素、丹参酮IIA、黄芪甲苷及四君子汤等可调控铁死亡相关信号通路。
  • 中医药通过多靶点、多途径减轻氧化损伤并促进黏膜修复,为CAG治疗提供新方向。

核心结论

  • 中医药通过调控铁死亡相关信号通路,可能为CAG管理提供多靶点、多途径的治疗策略。

研究设计与样本

  • 本文为综述,系统阐述铁死亡在CAG发病中的分子机制并总结中药活性成分与复方调控铁死亡的研究进展。

主要发现

  • 铁死亡通过铁代谢失衡、GSH耗竭、LPO、线粒体功能障碍和炎症反应等九条核心通路驱动CAG胃黏膜损伤与疾病进展。
  • 黄芩素、姜黄素、丹参酮IIA、黄芪甲苷等中药活性成分及四君子汤、半夏泻心汤、摩罗丹、胃复春等经典复方可调控铁死亡相关信号通路。
  • 中医药在减轻氧化损伤和促进黏膜修复方面呈现多靶点、多途径特征。

关键数值与推荐

  • CAG核心病机为脾胃虚弱为本,气滞、血瘀、湿热为标。
  • 中医治疗策略包括健脾益气、清热化湿、活血化瘀。

临床怎么用

  • 临床可基于铁死亡调控机制,选用具有调控铁死亡相关通路证据的中药活性成分或复方辅助管理CAG。
  • 重视健脾益气、清热化湿、活血化瘀治法在CAG全程管理中的协同作用。

局限性

  • 本文为综述,未报告原始临床研究数据或疗效评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic atrophic gastritis (CAG) is a major precancerous lesion of gastric cancer, characterized by a high incidence rate, a protracted clinical course, and a well-documented risk of malignant transformation. Current Western medical treatments exert limited efficacy in reversing progressive gastric mucosal damage. In traditional Chinese medicine (TCM), CAG is categorized as expressing symptoms such as "stomachache" and "abdominal fullness," with the core pathogenesis defined as "spleen-stomach deficiency as the root, and qi stagnation, blood stasis, and damp-heat as the superficial manifestations." TCM confers distinct clinical advantages through therapeutic strategies which include invigorating the spleen and replenishing qi, clearing heat and resolving dampness, and promoting blood circulation to remove stasis. Ferroptosis, an iron-dependent form of regulated cell death, has been increasingly recognized as a key driver of gastric mucosal injury and disease progression in CAG, and exerts its effects via nine core pathways including iron metabolism imbalance, glutathione (GSH) depletion, lipid peroxidation (LPO), mitochondrial dysfunction, and inflammatory responses. This review systematically elaborates on the molecular mechanisms of ferroptosis in CAG pathogenesis and comprehensively summarizes recent advances in how active ingredients derived from Chinese herbal medicines (such as baicalein, curcumin, tanshinone IIA, astragaloside IV) and classic compound formulas like Sijunzi Decoction, Banxia Xiexin Decoction, Moluodan, and Weifuchun regulate ferroptosis-related signaling pathways. It further highlights the multi-target, multi-pathway characteristics of TCM in alleviating oxidative damage and promoting mucosal repair. Ultimately, this review aims to elucidate the scientific basis of TCM-mediated ferroptosis regulation in CAG management, provide novel theoretical support for clinical practice, and guide future directions for drug research and development.

来源:Am J Chin Med,查看原文。版权归原作者所有。

引用

  1. Gu H, Chen Y, Lin Y, et al. Modulation of Ferroptosis: A Novel Mechanism of Traditional Chinese Medicine in Managing Chronic Atrophic Gastritis. Am J Chin Med. 2026. PMID: 42366517. doi:10.1142/S0192415X26500394

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。